Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss
Public ClinicalTrials.gov record NCT02616172. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety of Infusion of Autologous Human Bone Marrow Mononuclear Fraction in Children With Sensorineural Hearing Loss
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Autologous human bone marrow mononuclear fraction (BMMF) will be harvested and given to children with bilateral moderate to severe sensorineural hearing loss. The aim is to determine if bone marrow mononuclear fraction (BMMF) infusion is safe, feasible, improves inner ear function, audition, and language development.
Study identification
- NCT ID
- NCT02616172
- Recruitment status
- Suspended
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 10 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years to 6 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2015
- Primary completion
- Aug 31, 2022
- Completion
- Aug 31, 2022
- Last update posted
- Mar 17, 2022
2015 – 2022
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Florida Hospital for Children | Orlando | Florida | 32803 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Sensorineural Hearing Loss trials
Other public records listing Sensorineural Hearing Loss. Sorted by last update posted; newest first. Not a recommendation.
- NCT07039435: Perceptual Adaptation Following Cochlear Implantation (Aim 3a) Recruiting
- NCT06699797: Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant Active, not recruiting
- NCT07081542: Comparative Analysis of Hearing Outcomes: Robotic vs. Manual Insertion of Cochlear Implants Not yet recruiting
- NCT06936449: Long-term Follow-up of a Cochlear Implant With Dexamethasone Eluting Electrode Array Recruiting
- NCT05107466: Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss Recruiting
- NCT06226558: Long-Term Outcomes of Children With Congenital CMV in New York State Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02616172, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 17, 2022 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02616172 live on ClinicalTrials.gov.